Pfizer Inc. (PFE)
Pfizer Inc. is a global pharmaceutical company known for its research and development of innovative medicines and vaccines. Founded in 1849, it has a diverse portfolio that includes treatments for various medical conditions, and it played a key role in developing one of the first COVID-19 vaccines. Pfizer operates in multiple healthcare sectors, including biopharmaceuticals, oncology, and immunology.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 2, 2025 | $0.43 | 2025-07-25 | 2025-07-25 |
| June 13, 2025 | $0.43 | 2025-05-09 | 2025-05-09 |
| March 7, 2025 | $0.43 | 2025-01-24 | 2025-01-24 |
| December 2, 2024 | $0.42 | 2024-11-08 | 2024-11-08 |
| September 3, 2024 | $0.42 | 2024-07-26 | 2024-07-26 |
Dividends Summary
- Pfizer Inc. has issued 87 dividend payments over the past 21 years
- The most recent dividend was paid 18 days ago, on September 2, 2025
- The highest dividend payed out to investors during this period was $0.43 per share
- The average dividend paid during this period was $0.30 per share.
Company News
The global maternal mental health market is projected to grow from $10.32 billion in 2024 to $126.33 billion by 2034, driven by increasing awareness of perinatal mental health issues, technological advancements, and reduced stigma around mental health conditions.
Moderna released preliminary data on its 2025-2026 COVID-19 vaccine formula, showing an 8-fold increase in neutralizing antibodies against the LP.8.1 variant for high-risk adults and seniors, with no new safety concerns identified.
The article discusses three S&P 500 dividend stocks trading at a discount: Pfizer, Accenture, and Occidental Petroleum, highlighting their potential for long-term investment and income generation.
The healthcare sector is experiencing low valuations and potential for a quiet rebound, with improving technical indicators and significant institutional investment despite ongoing political and economic challenges.
During periods of heightened volatility, low-beta stocks can provide a valuable layer of defense and a more balanced risk profile. Northrop Grumman, Pfizer, and Kimberly-Clark have recently seen positive earnings estimate revisions, landing them in favorable Zacks Ranks.
